Related Experiment Video
Updated: Apr 18, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
MicroRNAs in alcoholic liver disease
Gyongyi Szabo1, Abhishek Satishchandran1
1Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Alcoholic liver disease (ALD) involves liver damage and inflammation, with alcohol altering microRNA (miRNA) profiles. Research explores miRNA roles in ALD pathogenesis, potential as biomarkers, and future miRNA-based therapies.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Alcoholic liver disease (ALD) is marked by liver cell damage, inflammation, and increased gut permeability.
- Alcohol consumption alters microRNA (miRNA) expression in the liver and circulation of ALD patients.
- Dysregulated miRNAs impact genes involved in inflammation, lipid metabolism, and cancer development in ALD.
Purpose of the Study:
- To review recent findings on miRNA expression and function in ALD pathogenesis.
- To discuss the significance of cell-specific and circulating extracellular miRNAs as potential ALD biomarkers.
- To evaluate the therapeutic potential of miRNA-based strategies for ALD.
Main Methods:
- Literature review of studies on miRNA expression and function in ALD.
- Analysis of research on alcohol's impact on miRNA profiles.
- Examination of studies investigating miRNA biomarkers and therapeutic applications.
Main Results:
- Alcohol significantly affects specific miRNAs, leading to abnormal profiles in ALD.
- Altered miRNAs regulate key pathways implicated in ALD, including inflammation, lipid metabolism, and oncogenesis.
- Extracellular miRNAs show promise as non-invasive biomarkers for ALD detection and monitoring.
Conclusions:
- MicroRNAs play a critical role in the molecular mechanisms underlying ALD.
- miRNAs, particularly circulating ones, represent promising biomarkers for ALD.
- miRNA-targeted therapies offer a potential new avenue for ALD treatment.
More Related Videos
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
MicroRNAs
Chronic Pancreatitis II: Pathophysiology